The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia – A review and meta-analysis

BACKGROUND: Miltefosine (MF) is the only oral drug available for treatment of visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). Although the drug is effective and well tolerated in treatment of VL, the efficacy and safety of MF for longer treatment durations (>28 days) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pijpers, Joyce, den Boer, Margriet L., Essink, Dirk R., Ritmeijer, Koert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386412/
https://www.ncbi.nlm.nih.gov/pubmed/30742620
http://dx.doi.org/10.1371/journal.pntd.0007173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386412/
https://www.ncbi.nlm.nih.gov/pubmed/30742620
http://dx.doi.org/10.1371/journal.pntd.0007173

Ejemplares similares